These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34922279)

  • 1. From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience.
    Pouget JP; Santoro L; Piron B; Paillas S; Ladjohounlou R; Pichard A; Poty S; Deshayes E; Constanzo J; Bardiès M
    Nucl Med Biol; 2022; 104-105():53-64. PubMed ID: 34922279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to radiobiology of targeted radionuclide therapy.
    Pouget JP; Lozza C; Deshayes E; Boudousq V; Navarro-Teulon I
    Front Med (Lausanne); 2015; 2():12. PubMed ID: 25853132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclides in radiation-induced bystander effect; may it share in radionuclide therapy?
    Widel M
    Neoplasma; 2017; 64(5):641-654. PubMed ID: 28592116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry in nuclear medicine therapy: radiobiology application and results.
    Strigari L; Benassi M; Chiesa C; Cremonesi M; Bodei L; D'Andrea M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):205-21. PubMed ID: 21386791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT).
    Grzmil M; Boersema P; Sharma A; Blanc A; Imobersteg S; Pruschy M; Picotti P; Schibli R; Behe M
    J Hematol Oncol; 2022 Aug; 15(1):123. PubMed ID: 36045419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Radiobiology of Radiopharmaceuticals.
    Morris ZS; Wang AZ; Knox SJ
    Semin Radiat Oncol; 2021 Jan; 31(1):20-27. PubMed ID: 33246632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of radiobiological concepts in radionuclide therapy of cancer.
    Kumar C; Shetake N; Desai S; Kumar A; Samuel G; Pandey BN
    Int J Radiat Biol; 2016; 92(4):173-86. PubMed ID: 26917443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic.
    Bellavia MC; Patel RB; Anderson CJ
    J Nucl Med; 2022 Nov; 63(11):1636-1641. PubMed ID: 36215570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour therapy with radionuclides: assessment of progress and problems.
    Carlsson J; Forssell Aronsson E; Hietala SO; Stigbrand T; Tennvall J
    Radiother Oncol; 2003 Feb; 66(2):107-17. PubMed ID: 12648782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Radiobiology of Targeted Alpha Therapy.
    Pouget JP; Constanzo J
    Front Med (Lausanne); 2021; 8():692436. PubMed ID: 34386508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-targeted effects as a paradigm breaking evidence.
    Averbeck D
    Mutat Res; 2010 May; 687(1-2):7-12. PubMed ID: 20080109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy.
    Verger E; Cheng J; de Santis V; Iafrate M; Jackson JA; Imberti C; Fruhwirth GO; Blower PJ; Ma MT; Burnham DR; Terry SYA
    Nucl Med Biol; 2021; 100-101():36-43. PubMed ID: 34153932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Research Campaign review of radiobiology research.
    Horwich A
    Br J Cancer; 1993 Jan; 67(1):198-201. PubMed ID: 8094004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological effectiveness of targeted radionuclide therapy based on a whole-body pharmacokinetic model.
    Grudzinski JJ; Tomé W; Weichert JP; Jeraj R
    Phys Med Biol; 2010 Oct; 55(19):5723-34. PubMed ID: 20826898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy.
    Nonnekens J; Cornelissen B; Terry SYA;
    J Nucl Med; 2023 Nov; 64(11):1788-1790. PubMed ID: 37442600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced bystander effects and the DNA paradigm: an "out of field" perspective.
    Mothersill C; Seymour CB
    Mutat Res; 2006 May; 597(1-2):5-10. PubMed ID: 16414088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular radiation effects and the bystander response.
    Little JB
    Mutat Res; 2006 May; 597(1-2):113-8. PubMed ID: 16413041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical animal research on therapy dosimetry with dual isotopes.
    Konijnenberg MW; de Jong M
    Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S19-27. PubMed ID: 21484379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
    Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.